New research on HIV prevention funding exposes the cost of donor dependence, making the case for domestic investment in science and innovation more urgent than ever.
A new academic paper examining domestic resource mobilisation for HIV prevention research in Kenya could hardly have come at a more opportune time. Published on November 18, 2026, the study, titled “It Stops Us from Having to Dance to the Song that Hasn’t Been Played yet”: Kenyan Valueholders’ Perspectives on Decolonization and Domestic Resource Mobilization for HIV Prevention Research, makes an important argument that Kenya and other African countries can no longer afford to ignore: Whoever pays for research often has considerable influence over what gets researched, whose priorities are pursued and who ultimately benefits from the findings.
The paper, published in the Journal of the International Association of Providers of AIDS Care, is timely because it speaks to a much bigger question than the financing of HIV prevention. It goes to the heart of Kenya’s ability to determine its own scientific, technological and health priorities, generate knowledge relevant to its people, and develop solutions to its challenges without having to depend excessively on the goodwill and priorities of external funders.
Led by Dr Angelo Katumba, the researchers point to a particularly revealing statistic: External funders financed approximately 68 per cent of Kenya’s overall HIV response in 2023. While the paper is careful to distinguish this figure from the separately unreported financing of HIV prevention research, the interviews and discussions conducted with Kenyan researchers, government officials, civil society representatives and health financing specialists reveal a troubling relationship between financial dependence and control over research agendas.
One of the study’s central observations is that financial dependence can translate into intellectual dependence. When the money comes from elsewhere, the priorities can also come from elsewhere. Kenyan researchers may find themselves responding to questions determined by foreign institutions rather than pursuing the questions that Kenyan communities, policymakers and health professionals consider most urgent.
The paper captures this predicament through the striking observation that those without control over the money can end up having to dance to a song whose tune they did not choose.
This is precisely why domestic resource mobilisation must become a central pillar of Kenya’s science, research and innovation policy, particularly in health. A country cannot realistically claim ownership of its development agenda when the financing of the knowledge required to drive that development is largely controlled by others.
The implications extend beyond HIV. Whether Kenya is researching emerging infectious diseases, developing vaccines, strengthening diagnostic capacity, studying antimicrobial resistance or investing in maternal and child health, it must have the financial capacity to set its own research agenda. This is not an argument against international scientific collaboration or development partnerships. Such partnerships are valuable and, in many instances, indispensable. It is an argument against a financing model in which international partners become so dominant that the country’s ability to make independent decisions is compromised.
The recent health financing arrangements between the Trump Administration and several African governments, including Kenya, provide an important illustration of this challenge.
In December 2025, Kenya became the first African country to sign a bilateral health cooperation framework with the Trump Administration under its America First Global Health Strategy. The five-year arrangement provides for more than US$1.6 billion in American health support, while Kenya commits to increasing its own health expenditure by US$850 million over the same period. Similar arrangements have subsequently been signed with other African governments.
On the surface, the agreements offer much-needed financial support at a time when the withdrawal and restructuring of American foreign assistance have left significant gaps in health financing. But there is a bigger question that African governments must confront: What happens when the financing of essential health services and programmes becomes dependent on the priorities and conditions of a foreign government?
The concerns are not merely theoretical. The agreements have attracted scrutiny over provisions relating to health data, pathogen samples and the terms governing access to information generated by national health systems. A Congressional Research Service assessment of US-Kenya relations notes that the Kenyan agreement has faced a court challenge. Meanwhile, a relatively recent BMJ investigation into the Trump Administration’s bilateral health agreements highlights concerns about the pressure on African governments to accept arrangements that may have implications for national sovereignty.
Kenya must be particularly careful here. Health data is a national strategic asset. Research findings, biological samples, disease surveillance information and the intellectual property arising from scientific discoveries are not simply technical resources. They have economic, security and public health implications.
There is nothing wrong with Kenya receiving American support, or support from any other development partner. Indeed, international cooperation is essential in confronting diseases that do not respect national borders. But assistance should strengthen Kenya’s capacity to make independent decisions, not create new forms of dependency or diminish its bargaining power.
A country that cannot finance its own research risks surrendering some control over the questions it asks, the evidence it generates and the solutions it develops. That is an unacceptable position for a country with Kenya’s scientific institutions, universities, research talent and ambitions.
It is against this backdrop that a recent proposal by the Parliamentary Budget Office (PBO) deserves considerable attention.
As we reported in our story on what next year’s budget could look like if the PBO gets its way, the office has recommended a significant increase in research and innovation funding. The PBO is proposing that Kenya progressively raises research and development funding towards 2 per cent of GDP. It has also proposed an additional Ksh2 billion allocation to the National Research Fund in the 2027/28 financial year.
The recommendation appears in the PBO’s November 2026 report, Strengthening Efficiency in Public Expenditure: Budget Options for FY 2027/2028 and the Medium Term. The report also calls for functional research and innovation infrastructure and greater private-sector investment in research.
This is a positive development, and one that deserves to be welcomed. Kenya’s research institutions have for too long operated with ambitions that are not always matched by the resources available to them. Increasing funding would give universities, research institutions and individual scientists greater opportunities to undertake locally relevant research, develop homegrown innovations and contribute more meaningfully to national development.
The proposed additional Ksh2 billion for the National Research Fund is particularly welcome. But it should be seen as a starting point rather than an adequate response to the country’s research financing needs.
Hopefully, this recommendation will find its way into the actual 2027/28 national budget. The PBO’s proposals are recommendations to inform budget deliberations, not approved appropriations. It is therefore incumbent upon the Treasury and Parliament to ensure that the ambition does not disappear between the publication of a policy document and the preparation and approval of the final budget.
Ultimately, this is about more than money. It is about sovereignty, national dignity and the right of a country to determine its own development priorities.
The new HIV prevention research paper makes this point particularly well. Its findings suggest that financial independence and the redistribution of decision-making authority must go hand in hand. Simply replacing foreign funding with domestic funding will not automatically decolonise research if the same exclusionary decision-making structures remain in place. Communities, local researchers and Kenyan institutions must also have a meaningful say in determining what gets researched and how the resulting knowledge is used.
That is an important distinction. Domestic financing must be accompanied by domestic ownership.
If Kenya wants to be a serious player in science, technology and innovation, it must be prepared to finance that ambition. If it wants to safeguard its health sovereignty, it must invest in its own research capacity. And if it wants solutions that respond to the needs of its people, it must be willing to pay for the research that generates those solutions.